Product Description
Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect.
The Prenatal and Newborn Genetic Testing market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Prenatal and Newborn Genetic Testing market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Prenatal and Newborn Genetic Testing Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Prenatal and Newborn Genetic Testing market are:
Natera
Qiagen
Biorad
Ariosa Diagnostics
Berry Genomics
Sequenom
Trivitron Healthcare
Laboratory Corporation of America
Verinata health
Illumina
BGI
Most important types of Prenatal and Newborn Genetic Testing products covered in this report are:
Molecular diagnosis
Screening check
Most widely used downstream fields of Prenatal and Newborn Genetic Testing market covered in this report are:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centres
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.